Steven M. Paul - Apr 1, 2022 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role: Director
Signature: By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Steven M. Paul
Stock symbol: ALNY
Transactions as of: Apr 1, 2022
Transactions value $: -$2,390,421
Form type: 4
Date filed: 4/5/2022, 04:05 PM
Previous filing: Feb 17, 2022
Next filing: Jun 17, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALNY	Common Stock	Options Exercise	$170K	+15K	+1500%	$11.33^*	16K	Apr 1, 2022	Direct	F1
transaction	ALNY	Common Stock	Sale	-$42K	-253	-1.58%	$166.04	15.7K	Apr 1, 2022	Direct	F1, F2
transaction	ALNY	Common Stock	Sale	-$836K	-4.95K	-31.42%	$168.95	10.8K	Apr 1, 2022	Direct	F1, F3
transaction	ALNY	Common Stock	Sale	-$827K	-4.87K	-45.12%	$169.71	5.93K	Apr 1, 2022	Direct	F1, F4
transaction	ALNY	Common Stock	Sale	-$211K	-1.24K	-20.84%	$171.16	4.69K	Apr 1, 2022	Direct	F1, F5
transaction	ALNY	Common Stock	Sale	-$247K	-1.43K	-30.56%	$172.10	3.26K	Apr 1, 2022	Direct	F1, F6
transaction	ALNY	Common Stock	Sale	-$111K	-642	-19.71%	$173.06	2.62K	Apr 1, 2022	Direct	F1, F7
transaction	ALNY	Common Stock	Sale	-$15.7K	-90	-3.44%	$174.33	2.53K	Apr 1, 2022	Direct	F1
transaction	ALNY	Common Stock	Sale	-$92.8K	-526	-20.82%	$176.51	2K	Apr 1, 2022	Direct	F1, F8
transaction	ALNY	Common Stock	Sale	-$147K	-825	-41.25%	$177.58	1.18K	Apr 1, 2022	Direct	F1, F9
transaction	ALNY	Common Stock	Sale	-$31.3K	-175	-14.89%	$178.60	1K	Apr 1, 2022	Direct	F1

Showing 1 to 11 of 11 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALNY	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-15K	-100%	$0.00^*	0	Apr 1, 2022	Common Stock	15K	$11.33	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 29, 2021. The 15,000 options exercised and sold by the reporting person were due to expire on June 21, 2022.
F2	Sale prices ranged from $165.91 to $166.41.
F3	Sale prices ranged from $168.30 to $169.30.
F4	Sale prices ranged from $169.32 to $170.28.
F5	Sale prices ranged from $170.70 to $171.63.
F6	Sale prices ranged from $171.75 to $172.73.
F7	Sale prices ranged from $172.83 to $173.37.
F8	Sale prices ranged from $176.04 to $176.88.
F9	Sale prices ranged from $177.12 to $178.00.